Skip to main content

Table 3 Lung function in the two different groups of patients with acute atypical infection (AAI) and patients without AAI during the study period.

From: Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection

  Patients with AAI (22) Patients without AAI (36) p
PEF predicted (L/min) 546.9 ± 85.4 509.8 ± 101.9 0.159
PEF admission (L/min) 205.9 ± 104.1 276.9 ± 117.3 0.023
PEF % of predicted on admission 38.3 ± 18.3 55.3 ± 19.5 0.002
FEV1% on admission 39.73 ± 19.64 (11 pts) 58.53 ± 20.43 (19 pts) 0.02
FEV1% Visit 1 (2–4 days) 70.91 ± 25.6 89.14 ± 17.07 0.002
FEV1% Visit 2 (10–14 days) 76.30 ± 24.54 92.91 ± 13.89 0.002
FEV1% Visit 3 (4–8 weeks) 85.05 ± 19.13 92.26 ± 14.44 0.114
Acute severe attack (number of patients) 15 12 0.01
OR 4.29, 95% CI 1.38–13.32